ViroPharma reports earnings, Cinryze guidance

ViroPharma Inc. (NASDAQ:VPHM) reported diluted GAAP EPS of $0.20, beating by $0.02 the Street's estimate of $0.18, but down 31%

Read the full 203 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE